NEW YORK, Oct. 8 /PRNewswire-USNewswire/ -- The Physicians Coalition for Injectable Safety today issued a consumer warning that fat dissolving, fat melting, injection lipolysis or other injectable treatments touted to reduce localized body fat are unproven medical treatments. These should not be mistaken as an accepted medical or cosmetic treatment of localized fat reduction.
"Injections to unwanted fat, using compounded pharmaceuticals, or herbal agents, claim a medical result -- the degradation (breakdown) of adipose (body fat) and it's excretion from the body," said Julius Few, MD, associate professor of plastic surgery at Northwestern University Feinberg School of Medicine, in Chicago and a member of the Coalition. "To date, the substances in these injections have not gone through FDA sanctioned clinical trials or the research necessary to document the medical results claimed or clearly identify the potential underlying complications."
The Coalition advises consumers of the importance of FDA approval for any pharmaceutical injected into the body. An injected substance that is not FDA approved should only be used as part of a formal clinical trial. "Clinical trials cannot be marketed, they can only be offered to patients who are already seeking some form of medical intervention for a condition, in this case, the reduction of localized fat," said coalition leader Roger A. Dailey, MD, FACS, of Portland, Oregon and professor at Oregon Health & Sciences University. "In addition, anyone who agrees to participate in a clinical trial is essentially agreeing to be a test subject."
"There is presently not valid research on fat-melting injections that
demonstrate reproducible, safe outcomes. Consumers should not ignore the
proliferation of blogs and media that are reporting the ineffectiveness and
the complications experienced by fat-melting injections," added Dr. Dailey.
"There is much more unknown and unproven about these injections than there
|SOURCE American Society for Aesthetic Plastic Surgery|
Copyright©2007 PR Newswire.
All rights reserved